Immuneering Corp (IMRX)
1.54
+0.12
(+8.45%)
USD |
NASDAQ |
May 01, 16:00
1.54
0.00 (0.00%)
After-Hours: 19:47
Immuneering Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
Date | Value |
---|---|
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2020
--
Maximum
Dec 2020
--
Average
--
Median
Dec 2020
Debt to Equity Ratio Benchmarks
Geron Corp | 0.3305 |
SELLAS Life Sciences Group Inc | -- |
Elicio Therapeutics Inc | -- |
Vistagen Therapeutics Inc | 0.00 |
ADMA Biologics Inc | 0.9659 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 102.58M |
Total Liabilities (Quarterly) | 12.01M |
Shareholders Equity (Quarterly) | 90.58M |